Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. .

Özgül, N; Köse, MEHMET; Keskin, HL; Turan, AT; Karalök, MA; Üreyen, I; Borani, N; Tulunay, HG

doi:10.3906/sag-1203-69

Addition of epirubicin to conventional chemotherapy in patients with advanced ovarian cancer: sequential therapy -a retrospective evaluation. .

Atıf İçin Kopyala

Özgül N., Köse M. F., Keskin H., Turan A., Karalök M., Üreyen I., ...Daha Fazla

Turkish journal of medical sciences, cilt.44, ss.212-9, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 44
Basım Tarihi: 2014
Doi Numarası: 10.3906/sag-1203-69
Dergi Adı: Turkish journal of medical sciences
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Sayfa Sayıları: ss.212-9
Anahtar Kelimeler: Epithelial ovarian cancer, gynecological oncology, chemotherapy
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

Aim: To evaluate the effectiveness of the addition of epirubicin to conventional chemotherapy as a first-line therapy for stage III-IV epithelial ovarian cancer.